Date Insider Type Main position Quantity % Market Cap.
8/28/20 Tax

General Counsel

997 0.0007%
8/28/20 Tax

Executive/Senior Manager

281 0.0002%
8/28/20 Tax

Chief Financial Officer

256 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
-1.12%-5.49%+60.19%+112.43% 1,060B
-1.57%-0.60%+50.33%+59.86% 651B
-1.81%-1.41%+24.07%+75.98% 465B
-1.17%-2.10%+38.61%+40.43% 365B
-2.00%-1.35%+22.22%+38.92% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.76%+0.75%+51.75%+70.45% 238B
-3.18%-0.30%-17.23%-53.79% 210B
+0.52%+3.78%+30.67%+93.68% 184B
Average -1.14%-0.07%+29.18%+50.01% 414.49B
Weighted average by Cap. -1.36%-1.46%+38.43%+65.86%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock